Study of molecular interactions with 13C DNP-NMR

Journal of Magnetic Resonance

Volumn 203, Issue 1, 2010, Pages 52-56

  Lerche, Mathilde H ^a   Meier, Sebastian ^b   Jensen, Pernille R ^a   Baumann, Herbert ^c   Petersen, Bent O ^b   Karlsson, Magnus ^a   Duus, Jens Ø ^b   Ardenkjær Larsen, Jan H ^d  

^a Albeda Research   (Denmark)

^b CARLSBERG LABORATORY   (Denmark)

^c BIACORE AB   (Sweden)

^d GE HEALTHCARE   (United States)

Author keywords

Dissolution DNP; Ligand binding; Screening

Indexed keywords

DISSOLUTION DNP; DYNAMIC NUCLEAR POLARIZATION; ENZYMATIC ASSAY; ENZYME INHIBITORS; HYPERPOLARIZATION; HYPERPOLARIZED; IN-VITRO; ISOTOPIC ABUNDANCES; LIGAND BINDING; MATERIAL REQUIREMENTS; NMR SPECTROSCOPY; NON EQUILIBRIUM; NUCLEAR SPINS; ORDERS OF MAGNITUDE; SIGNAL ENHANCEMENT; SYNTHETIC MODIFICATIONS;

ACTIVE NETWORKS; DISSOLUTION; MOLECULAR INTERACTIONS; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARAMAGNETIC RESONANCE; SPIN DYNAMICS; SPIN POLARIZATION;

LIGANDS;

ASCORBIC ACID; LIGAND; SALICYLIC ACID DERIVATIVE; SERUM ALBUMIN; UREASE;

ARTICLE; CHEMISTRY; ENZYME ASSAY; ENZYMOLOGY; HUMAN; KINETICS; LEGUME; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE; PROTEIN BINDING;

ASCORBIC ACID; ENZYME ASSAYS; FABACEAE; HUMANS; KINETICS; LIGANDS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN BINDING; SALICYLATES; SERUM ALBUMIN; UREASE;

EID: 75749107761     PISSN: 10907807     EISSN: 10960856     Source Type: Journal    
DOI: 10.1016/j.jmr.2009.11.020     Document Type: Article

References (35)

1. Coles M., Heller M., and Kessler H. NMR-based screening technologies. Drug Discovery Today 8 (2003) 803-810
2. Diercks T., Coles M., and Kessler H. Applications of NMR in drug discovery. Curr. Opin. Chem. Biol. 5 (2001) 285-291
3. Ludwig C., and Guenther U.L. Ligand based NMR methods for drug discovery. Front. Biosci. 14 (2009) 4565-4574
4. Pellecchia M., Bertini I., Cowburn D., Dalvit C., Giralt E., Jahnke W., James T.L., Homans S.W., Kessler H., Luchinat C., Meyer B., Oschkinat H., Peng J., Schwalbe H., and Siegal G. Perspectives on NMR in drug discovery: a technique comes of age. Nat. Rev. Drug Discov. 7 (2008) 738-745
5. Chen A., and Shapiro M.J. NOE pumping: a novel NMR technique for identification of compounds with binding affinity to macromolecules. J. Am. Chem. Soc. 120 (1998) 10258-10259
6. Chen A., and Shapiro M.J. NOE pumping. 2. A high-throughput method to determine compounds with binding affinity to macromolecules by NMR. J. Am. Chem. Soc. 122 (2000) 414-415
7. Hajduk P.J., Olejniczak E.T., and Fesik S.W. One-dimensional relaxation- and diffusion-edited NMR methods for screening compounds that bind to macromolecules. J. Am. Chem. Soc. 119 (1997) 12257-12261
8. Jahnke W., Perez L.B., Paris C.G., Strauss A., Fendrich G., and Nalin C.M. Second-site NMR screening with a spin-labeled first ligand. J. Am. Chem. Soc. 122 (2000) 7394-7395
9. Jahnke W., Rudisser S., and Zurini M. Spin label enhanced NMR screening. J. Am. Chem. Soc. 123 (2001) 3149-3150
10. Lin M., Shapiro M.J., and Wareing J.R. Diffusion-edited NMR; affinity NMR for direct observation of molecular interactions. J. Am. Chem. Soc. 119 (1997) 5249-5250
11. Meyer B., and Peters T. NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew. Chem. Int. Ed. Engl. 42 (2003) 864-890
12. Stockman B.J., and Dalvit C. NMR screening techniques in drug discovery and drug design. Prog. Nucl. Magn. Reson. Spectrosc. 41 (2002) 187-231
13. LaPlante S.R., Aubry N., Deziel R., Ni F., and Xu P. Transferred 13C T1 relaxation at natural isotopic abundance; a practical method for determining site-specific changes in ligand flexibility upon binding to a macromolecule. J. Am. Chem. Soc. 122 (2000) 12530-12535
14. Gossert A.D., Henry C., Blommers M.J.J., Jahnke W., and Fernandez C. Time efficient detection of protein-ligand interactions with the polarization optimized PO-WaterLOGSY NMR experiment. J. Biomol. NMR 43 (2009) 211-217
15. Clarkson J., and Campbell I.D. Studies of protein-ligand interactions by NMR. Biochem. Soc. Trans. 31 (2003) 1006-1009
16. Dalvit C., Fagerness P.E., Hadden D.T.A., Sarver R.W., and Stockman B.J. Fluorine-NMR experiments for high-throughput screening: theoretical aspects, practical considerations, and range of applicability. J. Am. Chem. Soc. 125 (2003) 7696-7703
17. Keun H.C., Beckonert O., Griffin J.L., Richter C., Moskau D., Lindon J.C., and Nicholson J.K. Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. Anal. Chem. 74 (2002) 4588-4593
18. Abragam A., and Goldman M. Principles of dynamic nuclear polarisation. Rep. Prog. Phys. 41 (1978) 395-467
19. Ardenkjær-Larsen J.H., Fridlund B., Gram A., Hansson G., Hansson L., Lerche M.H., Servin R., Thaning M., and Golman K. Increase in signal-to-noise ratio of >10, 000 times in liquid-state NMR. Proc. Natl Acad. Sci. USA 100 (2003) 10158-10163
20. Peters J.T. Ligand Binding by Albumin, All About Albumin (1995), Academic Press, San Diego pp. 76-132
21. Wang Z.-X. An exact mathematical expression for describing competitive binding of two different ligands to a protein molecule. FEBS Lett. 360 (1995) 111-114
22. Allerhand A., Doddrell D., Glushko V., Cochran D.W., Wenkert E., Lawson P.J., and Gurd F.R.N. Conformation and segmental motion of native and denatured ribonuclease A in solution. Application of natural-abundance carbon-13 partially relaxed Fourier transform nuclear magnetic resonance. J. Am. Chem. Soc. 93 (1971) 544-546
23. Johannesson H., Macholl S., and Ardenkjaer-Larsen J.H. Dynamic nuclear polarization of [1-13C]pyruvic acid at 4.6 tesla. J. Magn. Reson. 197 (2009) 167-175
24. Bowen S., and Hilty C. Time-resolved dynamic nuclear polarization enhanced NMR spectroscopy. Angew. Chem. Int. Ed. Engl. 47 (2008) 5235-5237
25. Jensen P.R., Karlsson M., Meier S., Duus J.Ø., and Lerche M.H. Hyperpolarized amino acids for in vivo assays of transaminase activity. Chemistry 15 (2009) 10010-10012
26. Jensen P.R., Meier S., Ardenkjaer-Larsen J.H., Duus J.O., Karlsson M., and Lerche M.H. Detection of low-populated reaction intermediates with hyperpolarized NMR. Chem. Commun. 34 (2009) 5168-5170
27. Merritt M.E., Harrison C., Storey C., Jeffrey F.M., Sherry A.D., and Malloy C.R. Hyperpolarized 13C allows a direct measure of flux through a single enzyme-catalyzed step by NMR. Proc. Natl. Acad. Sci. USA 104 (2007) 19773-19777
28. Golman K., in 't Zandt R., and Thaning M. Real-time metabolic imaging. Proc. Natl. Acad. Sci. USA 103 (2006) 11270-11275
29. Barros T.G., Williamson J., Antunes O.A.C., and Muri E.M.F. Hydroxamic acids designed as inhibitors of urease. Lett. Drug Des. Discov. 6 (2009) 186-192
30. Krajewska B., and Zaborska W. The effect of phosphate buffer in the range of pH 5.80-8.07 on jack bean urease activity. J. Mol. Catal. B Enzym. 6 (1999) 75-81
31. i) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
32. Rosenstein I.J., Hamilton-Miller J.M., and Brumfitt W. Role of urease in the formation of infection stones: comparison of ureases from different sources. Infect. Immun. 32 (1981) 32-37
33. Blommers M.J.J., Stark W., Jones C.E., Head D., Owen C.E., and Jahnke W. Transferred cross-correlated relaxation complements transferred NOE: structure of an IL-4R-derived peptide bound to STAT-6. J. Am. Chem. Soc. 121 (1999) 1949-1953
34. Carlomagno T., Felli I.C., Czech M., Fischer R., Sprinzl M., and Griesinger C. Transferred cross-correlated relaxation: application to the determination of sugar pucker in an aminoacylated tRNA-mimetic weakly bound to EF-Tu. J. Am. Chem. Soc. 121 (1999) 1945-1948
35. J.H. Ardenkjaer-Larsen, J. Urbahn, A. Leach, E. Stautner, T. Zhang, N. Clarke, A closed helium sorption pump system and its use in hyperpolarized 13C metabolic imaging, in: 2nd DNP Symposium, Königstein, 2009, p. 38.